Medicenna Therapeutics Corp (MDNAF)

$0.71 -0.01 (-1.36%)
Market Cap 59.24M
Revenue (ttm) 0.00
Net Income (ttm) -8.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 111,900
Avg Vol 48,252
Day's Range N/A - N/A
Shares Out 83.41M
Stochastic %K 73%
Beta 1.70
Analysts Strong Sell
Price Target $4.03

Company Profile

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15...

Industry: Biotechnology
Sector: Healthcare
Phone: 416 648 5555
Address:
2 Bloor Street West, Suite 903 7th Floor, Toronto, Canada
_Osmium
_Osmium Oct. 3 at 4:11 PM
$MDNAF Volume uptick on a Friday is unusual. Not doing much pricewise, but worth noting. Also, a 2 month long descending wedge for those looking at technicals. Lastly, I've mentioned before, read the Substack of David's; it's high level but if he's right regarding scaffolding and how Medicenna is positioning itself, then this investment will prove successful one day.
1 · Reply
rudazur2
rudazur2 Oct. 1 at 10:13 PM
$MDNAF 9-10 october another investor conference, nothing to wait for us
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Oct. 1 at 2:11 PM
$MDNAF I wonder if Fahar is attending SITC in November, he’s sitting on 5 months of data…
2 · Reply
NewbJackCity
NewbJackCity Sep. 26 at 2:52 PM
$MDNAF price tanking again, they must’ve released a PR or spoke at some conference is my guess.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Sep. 26 at 3:38 AM
$MDNAF Min 7:40. He pretty much says what they are seeing…20-30% ORR ( to be presented before year-end), that combined with the durability previously shown should be a slam dunk for accelerated approval.
1 · Reply
Pilotboy1985
Pilotboy1985 Sep. 25 at 8:14 PM
$MDNAF watched the presentation from today's Emerging Growth Conference. Fahar is confident we'll have read outs before the end of the year on mdna11. It looks to be promising. He mentions they are continuing to try and partner for MDNA55. This procurement of a partnership seems to be taking a really long time though. Video of presentation https://youtu.be/THJhG80Wq8Y?si=kEljiGknFIABUecE
0 · Reply
rudazur2
rudazur2 Sep. 24 at 12:57 PM
$MDNAF waiting for a PR to know when we will have updated data. Seem short for october but maybe end of october / november ? Remember we should have data for more than 100 patient this time
1 · Reply
boomshiva
boomshiva Sep. 23 at 4:09 PM
$MDNAF
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Sep. 12 at 6:55 PM
$MDNAF As @Spartrap as previously noted open label study. I asked AI to analyze share volume over the last two years. The following is the result, does this correspond to imaging data collection I wonder? • Roughly every 2–3 months, there’s a major volume cluster: • Sep 2024 • Nov 2024 • Dec 2024 / Jan 2025 • Feb / Mar 2025 • May 2025 • Aug 2025 • This may coincide with quarterly reporting cycles or regular biotech catalysts. ⸻ ✅ In short: • Clusters of high-volume trading appear every 2–3 months. • They usually last several days in a row, not just one. • Likely tied to company news or biotech sector events.
2 · Reply
boomshiva
boomshiva Sep. 12 at 2:22 PM
$MDNAF Not related to SP, but still cool...... I went to the co website and their AI popped up. Never seen that on a co site before. Very cool.
1 · Reply
Latest News on MDNAF
No data available.
_Osmium
_Osmium Oct. 3 at 4:11 PM
$MDNAF Volume uptick on a Friday is unusual. Not doing much pricewise, but worth noting. Also, a 2 month long descending wedge for those looking at technicals. Lastly, I've mentioned before, read the Substack of David's; it's high level but if he's right regarding scaffolding and how Medicenna is positioning itself, then this investment will prove successful one day.
1 · Reply
rudazur2
rudazur2 Oct. 1 at 10:13 PM
$MDNAF 9-10 october another investor conference, nothing to wait for us
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Oct. 1 at 2:11 PM
$MDNAF I wonder if Fahar is attending SITC in November, he’s sitting on 5 months of data…
2 · Reply
NewbJackCity
NewbJackCity Sep. 26 at 2:52 PM
$MDNAF price tanking again, they must’ve released a PR or spoke at some conference is my guess.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Sep. 26 at 3:38 AM
$MDNAF Min 7:40. He pretty much says what they are seeing…20-30% ORR ( to be presented before year-end), that combined with the durability previously shown should be a slam dunk for accelerated approval.
1 · Reply
Pilotboy1985
Pilotboy1985 Sep. 25 at 8:14 PM
$MDNAF watched the presentation from today's Emerging Growth Conference. Fahar is confident we'll have read outs before the end of the year on mdna11. It looks to be promising. He mentions they are continuing to try and partner for MDNA55. This procurement of a partnership seems to be taking a really long time though. Video of presentation https://youtu.be/THJhG80Wq8Y?si=kEljiGknFIABUecE
0 · Reply
rudazur2
rudazur2 Sep. 24 at 12:57 PM
$MDNAF waiting for a PR to know when we will have updated data. Seem short for october but maybe end of october / november ? Remember we should have data for more than 100 patient this time
1 · Reply
boomshiva
boomshiva Sep. 23 at 4:09 PM
$MDNAF
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Sep. 12 at 6:55 PM
$MDNAF As @Spartrap as previously noted open label study. I asked AI to analyze share volume over the last two years. The following is the result, does this correspond to imaging data collection I wonder? • Roughly every 2–3 months, there’s a major volume cluster: • Sep 2024 • Nov 2024 • Dec 2024 / Jan 2025 • Feb / Mar 2025 • May 2025 • Aug 2025 • This may coincide with quarterly reporting cycles or regular biotech catalysts. ⸻ ✅ In short: • Clusters of high-volume trading appear every 2–3 months. • They usually last several days in a row, not just one. • Likely tied to company news or biotech sector events.
2 · Reply
boomshiva
boomshiva Sep. 12 at 2:22 PM
$MDNAF Not related to SP, but still cool...... I went to the co website and their AI popped up. Never seen that on a co site before. Very cool.
1 · Reply
rudazur2
rudazur2 Sep. 9 at 6:38 PM
$MDNAF huge ! 125 data patient for end of year on mdna11
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Sep. 5 at 5:10 PM
$MDNAF Wainwright on the 9th Sept, let’s hope we get an update!
1 · Reply
boomshiva
boomshiva Sep. 5 at 3:08 PM
$MDNAF With a MDNA11 data readout by the end of the year, it sure would be nice if they paired that good data with an uplist to the nasdaq.
2 · Reply
rudazur2
rudazur2 Sep. 2 at 9:07 PM
$MDNAF merck raised 6B$ maybe they will offer us 500M$ for our beloved
0 · Reply
Spartrap
Spartrap Sep. 2 at 5:02 PM
$MDNAF the company is as quiet as in 2018. Number of PRs cut in half basically compared to mean
2 · Reply
PennyQueen
PennyQueen Sep. 1 at 11:49 PM
$MDNAF $SPMEF $CHHYF $KGLDF
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Aug. 25 at 4:44 PM
$MDNAF she gets
2 · Reply
rudazur2
rudazur2 Aug. 21 at 10:03 PM
$MDNAF she want ?
0 · Reply
Spartrap
Spartrap Aug. 21 at 4:23 PM
$MDNAF *steepling intensifies*
0 · Reply
rudazur2
rudazur2 Aug. 20 at 3:54 PM
$MDNAF run baby run
0 · Reply
vu_jade
vu_jade Aug. 19 at 5:37 PM
$MDNAF targeting $10 in 2026
3 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Aug. 18 at 6:13 PM
$MDNAF No upcoming investors conferences attendances announced which is odd for them.
1 · Reply